Molecular Mechanisms of Acquired Proteasome Inhibitor Resistance-Reference-Cited by-同舟云学术

Molecular Mechanisms of Acquired Proteasome Inhibitor Resistance

Published:2012-10-03 Issue:23 Volume:55 Page:10317-10327
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Kale Andrew J.¹,Moore Bradley S.¹²

Affiliation:

1. Center for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, University of California—San Diego, La Jolla, California 92093, United States

2. Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California—San Diego, La Jolla, California 92093, United States

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm300434z

Reference65 articles.

1. Molecular mechanisms of proteasome assembly

2. 20S Proteasome and Its Inhibitors: Crystallographic Knowledge for Drug Development

3. Proteasome Inhibitors: Recent Advances and New Perspectives In Medicinal Chemistry

4. Proteasome inhibitors: antitumor effects and beyond

5. Proteasome inhibitor therapy for antibody-mediated rejection

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of Novel Nonpeptidic Proteasome Inhibitors Using Covalent Virtual Screening and Biological Evaluation;ACS Medicinal Chemistry Letters;2024-09-09

2. Toll-like receptor-1 (TLR-1) activation reduces immunoglobulin free light chain production by multiple myeloma cells in the context of bone marrow stromal cells and fibronectin;2024-09-03

3. Development of Proteasome Inhibitors for Cancer Therapy;International Journal of Drug Discovery and Pharmacology;2024-03-18

4. Decoding the secrets: how conformational and structural regulators inhibit the human 20S proteasome;Frontiers in Chemistry;2024-01-08

5. Crosstalk between hypoxic cellular micro-environment and the immune system: a potential therapeutic target for infectious diseases;Frontiers in Immunology;2023-07-31